Stock listing

Latigo Biotherapeutics, Inc.

Selected listing: LTGO · NASDAQ · USD · US

Latigo Biotherapeutics, Inc. (NASDAQ:LTGO), Health Technology. Latest release Sep 3, 2026: LTGO: Onzotrigine delivers rapid, superior pain relief with strong…

LTGO:NASDAQUSDUSUpdated October 3, 2026
Ticker
NASDAQ:LTGO
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

About Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc. (LTGO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Latigo Biotherapeutics, Inc.

LTGO: Onzotrigine delivers rapid, superior pain relief with strong opioid-sparing potential in late-stage trials

September 3, 2026

Latigo Biotherapeutics Price Target Announced at $36.00/Share by Leerink Partners

September 1, 2026

Latigo Biotherapeutics Ups IPO to 19.2 Million Shares

August 7, 2026

All Latigo Biotherapeutics, Inc. news →

Research Latigo Biotherapeutics, Inc.

Latigo Biotherapeutics, Inc. company profile

View the public company page for Latigo Biotherapeutics, Inc. on 6ix.

Latigo Biotherapeutics, Inc. news

Read company news and market updates connected to Latigo Biotherapeutics, Inc..

Latigo Biotherapeutics, Inc. investor events

Find investor webinars, events, and replay context for Latigo Biotherapeutics, Inc..

Alternate listings

LTGO:BOATS

US · USD

Alternate listing for Latigo Biotherapeutics, Inc.; the primary context on this page is LTGO:NASDAQ.